Linked Life Data

7673102

Source:http://linkedlifedata.com/resource/pubmed/id/7673102

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1995-10-17
pubmed:abstractText
Opioid neurotransmitter systems have been shown to mediate certain aspects of alcohol consumption in animals and in humans. Use of opioid antagonists appears to decrease alcohol consumption in animals. Controlled clinical trials have indicated that alcohol-dependent subjects who are treated with a combination of naltrexone, an opioid antagonist, and traditional psychological and social therapies consume less alcohol and have lower relapse rates. The neurobiological mechanisms by which naltrexone acts to reduce alcohol consumption are still being investigated; however, there is evidence that naltrexone modifies the reinforcing effects of alcohol. Some researchers suggest that the reinforcing stimulant effects of alcohol and other psychoactive substances play a primary role in initiating and maintaining substance abuse and dependence. These effects may be mediated through the action of endogenous opioids. This article discusses the possible mechanisms of action of naltrexone and reviews human and animal studies that support the use of naltrexone in the treatment of alcohol dependence.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0160-6689
pubmed:author
pubmed:issnType
Print
pubmed:volume
56 Suppl 7
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
24-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1995
pubmed:articleTitle
Effect of naltrexone on human alcohol consumption.
pubmed:affiliation
Department of Psychiatry, Roger Williams Medical Center, Providence, RI 02908, USA.
pubmed:publicationType
Journal Article, Review, Research Support, Non-U.S. Gov't